background variant influenza ahn virus hn transmit recent pig human unit state vaccine strategy need method health adult receive dose subversion vaccine Âµg hemagglutinindos day apart openlabel trial serum hemagglutin inhibit hai neutral next antibody ab tier measure dose memory cell mbc response ass result well tower total subject tier vaccine eighteen percent config inter ci year old respect p younger older develop fold rise signifies response pattern similar geometry mean higher provide enhance crossreact mbc detect expand preexist hnvspecif post correct early increase vaccineinduc concur one elicit level ab assoc protect studi child elderly individual india define immune need group clinic trial register not 